Beam Therapeutics Inc. (BEAM) Social Stream
BEAM THERAPEUTICS INC (BEAM) Price Targets From Analysts
Use the tables below to see what analysts covering BEAM THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 10 | $150 | $85 | $124.333 | $27.22 | 356.77% |
| 2021-12-22 | 11 | $150 | $85 | $121.555 | $27.22 | 346.57% |
| 2022-01-05 | 11 | $150 | $85 | $122.4 | $27.22 | 349.67% |
| 2022-01-10 | 11 | $159 | $85 | $124.5 | $27.22 | 357.38% |
| 2022-02-01 | 10 | $159 | $85 | $124.5 | $27.22 | 357.38% |
| 2022-02-28 | 10 | $159 | $85 | $126.25 | $27.22 | 363.81% |
| 2022-03-01 | 9 | $154 | $85 | $124.625 | $27.22 | 357.84% |
| 2022-05-09 | 8 | $154 | $110 | $130.285 | $27.22 | 378.64% |
| 2022-05-10 | 8 | $154 | $75 | $114.142 | $27.22 | 319.33% |
| 2022-05-11 | 8 | $130 | $75 | $110 | $27.22 | 304.11% |
| 2022-06-08 | 8 | $130 | $75 | $103.142 | $27.22 | 278.92% |
| 2022-06-17 | 9 | $130 | $41 | $95.375 | $27.22 | 250.39% |
| 2022-07-18 | 9 | $130 | $61 | $97.875 | $27.22 | 259.57% |
| 2022-08-10 | 10 | $130 | $60 | $92.666 | $27.22 | 240.43% |
| 2022-09-17 | 10 | $130 | $60 | $90.125 | $27.22 | 231.1% |
| 2022-11-07 | 10 | $130 | $60 | $89.222 | $27.22 | 227.78% |
| 2022-11-08 | 10 | $130 | $60 | $84.666 | $27.22 | 211.04% |
| 2022-12-13 | 11 | $130 | $60 | $82.4 | $27.22 | 202.72% |
| 2022-12-20 | 11 | $130 | $60 | $82.9 | $27.22 | 204.56% |
| 2023-01-06 | 10 | $103 | $60 | $77.222 | $27.22 | 183.7% |
| 2023-01-26 | 10 | $103 | $60 | $76.777 | $27.22 | 182.06% |
| 2023-02-01 | 11 | $103 | $60 | $75.3 | $27.22 | 176.63% |
| 2023-02-08 | 11 | $103 | $60 | $74.3 | $27.22 | 172.96% |
| 2023-03-01 | 12 | $103 | $60 | $74.1 | $27.22 | 172.23% |
| 2023-03-02 | 12 | $105 | $60 | $74.727 | $27.22 | 174.53% |
| 2023-04-11 | 13 | $105 | $37 | $71.583 | $27.22 | 162.98% |
| 2023-05-10 | 14 | $105 | $37 | $71.416 | $27.22 | 162.37% |
| 2023-05-11 | 14 | $105 | $37 | $69 | $27.22 | 153.49% |
| 2023-05-15 | 14 | $105 | $37 | $68.615 | $27.22 | 152.08% |
| 2023-06-06 | 14 | $105 | $37 | $68.461 | $27.22 | 151.51% |
| 2023-08-08 | 14 | $105 | $37 | $67 | $27.22 | 146.14% |
| 2023-08-09 | 14 | $105 | $35 | $65.615 | $27.22 | 141.05% |
| 2023-08-14 | 14 | $105 | $35 | $65.307 | $27.22 | 139.92% |
| 2023-09-07 | 14 | $105 | $35 | $63.23 | $27.22 | 132.29% |
| 2023-10-17 | 14 | $105 | $32 | $61.384 | $27.22 | 125.51% |
| 2023-10-19 | 14 | $105 | $32 | $60.615 | $27.22 | 122.69% |
| 2023-10-21 | 14 | $105 | $20 | $54 | $27.22 | 98.38% |
| 2023-10-31 | 14 | $95 | $20 | $53.333 | $27.22 | 95.93% |
| 2023-11-08 | 14 | $95 | $19 | $53.25 | $27.22 | 95.63% |
| 2023-11-14 | 14 | $95 | $19 | $51.833 | $27.22 | 90.42% |
| 2023-12-08 | 15 | $95 | $19 | $51.615 | $27.22 | 89.62% |
| 2023-12-15 | 15 | $95 | $19 | $50.153 | $27.22 | 84.25% |
The Trend in the Analyst Price Target
BEAM's average price target has moved up $18.4 over the prior 46 months.
Over the past 49 weeks, BEAM's average upside potential has been 122.15%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-06 | 11 | 103 | 60 | 74.300 | 47.91 | 55.08% |
| 2023-03-02 | 13 | 105 | 60 | 74.727 | 38.81 | 92.55% |
| 2023-05-15 | 14 | 105 | 37 | 68.461 | 35.99 | 90.22% |
| 2023-06-06 | 14 | 105 | 37 | 67.000 | 34.33 | 95.16% |
| 2023-10-19 | 14 | 105 | 32 | 60.615 | 18.36 | 230.15% |
BEAM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.07 | 7 | 0 | 8 | 0 | 0 | 15 |
The Trend in the Broker Recommendations
BEAM's average broker recommendation rating worsened by 0.5 over the prior 31 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BEAM as an investment opportunity.
- BEAM THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 4888.08% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, BEAM THERAPEUTICS INC's average analyst price target is greater than 4549.88% of them.
- In the context of stocks in the mid market cap category, BEAM THERAPEUTICS INC's number of analysts covering the stock is higher than 4422.06% of them.
- BEAM has a lower variance in analysts' estimates than -4229.56% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, PLX, EDIT, and FATE are the three stocks most similar to BEAM THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is BEAM a Buy, Hold or Sell? See the POWR Ratings now!